(Q39290064)

10 September 2017

title

Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells (English)

1 reference

10 September 2017

1 reference

ChEBI release 2020-05-28

1 reference

Ying-Ray Lee

9

0 references

author name string

Chin-Ho Kuo

1

1 reference

10 September 2017

Yin-Che Lu

2

1 reference

10 September 2017

Ya-Shin Tseng

3

1 reference

10 September 2017

Chung-Sheng Shi

4

1 reference

10 September 2017

Shu-Hsin Chen

5

1 reference

10 September 2017

Ping-Tzu Chen

6

1 reference

10 September 2017

Feng-Ling Wu

7

1 reference

10 September 2017

Yi-Ping Chang

8

1 reference

10 September 2017

publication date

28 August 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

21

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

358-369

1 reference

Facts and controversies in systemic treatment of metastatic breast cancer

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Breast cancer statistics, 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Reversine stimulates adipocyte differentiation and downregulates Akt and p70(s6k) signaling pathways in 3T3-L1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Reversine enhances generation of progenitor-like cells by dedifferentiation of annulus fibrosus cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Novel chemically defined approach to produce multipotent cells from terminally differentiated tissue syncytia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Reversine, a 2,6-disubstituted purine, as an anti-cancer agent in differentiated and undifferentiated thyroid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

"Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Mitotic kinases as regulators of cell division and its checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Overexpression and amplification of Aurora-A in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

The role of Aurora-A inhibitors in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Janus kinase 2--a novel negative regulator of estrogen receptor α function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

Naphtho[1,2-b]furan-4,5-dione disrupts Janus kinase-2 and induces apoptosis in breast cancer MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0400-Z

10.1007/S12282-012-0400-Z

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference